User login
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
Article Type
              
          Changed
              Thu, 01/10/2019 - 12:15
          Display Headline
              A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
          Article PDF
              
          Issue
              Cutis - 82(2)
          Publications
          
      Topics
          
      Page Number
              143-150
          Sections
          
      Article PDF
              
          Article PDF
              
          Issue
              Cutis - 82(2)
          Issue
              Cutis - 82(2)
          Page Number
              143-150
          Page Number
              143-150
          Publications
          
      Publications
          
      Topics
          
      Article Type
              
          Display Headline
              A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
          Display Headline
              A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
          Sections
          
      Article Source
              PURLs Copyright
              Inside the Article
              Article PDF Media
              Document